PARUL PATEL: Open Payments
NPI 1568881936 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$140 in 8 payments from 5 companies in 2025. Trend: 2023 $272 · 2024 $222 · 2025 $140
Food & beverage: $140
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 4 | $71 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $20 |
| Daiichi Sankyo Inc. | 1 | $17 |
| Astellas Pharma US Inc | 1 | $16 |
| CooperSurgical, Inc. | 1 | $15 |
Products named: MYFEMBREE, JOURNAVX, INJECTAFER, Veozah, Paragard T 380A.
Industry payments across FL — which companies pay providers there.
